Abstract
Theragnostic NPs give new hope in simultaneous diagnosis and therapy of a disease at curable stage. Theragnosis is the fundamental requirement of personalized medicine. For successful theragnosis applications, the imaging agents and drugs should be efficiently delivered, resulting in adequate imaging signal or drug concentration in the targeted disease site. The selection of NPs for imaging, diagnosis and therapy was based on their biomimetic features with higher surface to volume ratio of the nanomaterials. The essential properties of nanomedicines involve early and precise diagnosis of clinical conditions providing an efficient treatment without secondary effects. Thus, nanotheragnostic probes are much better than conventional treatments where the diagnosis and therapy are way apart from each other. This chapter briefs about the recent advancement of nanotheragnosis research with future scope and associated hurdles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acharya A (2013) Luminescent magnetic quantum dots for in vitro/in vivo imaging and applications in therapeutics. J Nanosci Nanotechnol 13:3753–3768
Acharya A, Rawat K, Bhat KA et al (2015) A multifunctional magneto-fluorescent nanocomposite for visual recognition of targeted cancer cells. Mater Res Express 2:115401
Ahmed N, Fessi H, Elaissari A (2012) Theranostic applications of nanoparticles in cancer. Drug Discov Today 17:928–934
Akerman ME, Chan WC, Laakkonen P et al (2002) Nanocrystal targeting in vivo. Proc Natl Acad Sci 99:12617–12621
Alexis F, Pridgen E, Molnar LK et al (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505–515
Alharbi KK, Al-sheikh YA (2014) Role and implications of nanodiagnostics in the changing trends of clinical diagnosis. Saudi J Biol Sci 21:109–117
Allen PM, Bawendi MG (2008) Ternary I-III-VI quantum dots luminescent in the red to near-infrared. J Am Chem Soc 130:9240–9241
Asín L, Goya GF, Tres A et al (2013) Induced cell toxicity originates dendritic cell death following magnetic hyperthermia treatment. Cell Death Dis 4:e596
Ballou B, Ernst LA, Andreko S et al (2007) Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug Chem 18:389–396
Barentsz J, Takahashi S, Oyen W et al (2006) Commonly used imaging techniques for diagnosis and staging. J Clin Oncol 24:3234–3244
Barnett SC, Riddell JS (2004) Olfactory ensheathing cells (OECs) and the treatment of CNS injury: advantages and possible caveats. J Anat 204:57–67
BBC Research. Nanotechnology in medical applications: the global market. Wellesley, MA, BBC Research, Jan 2010. http://www.bccresearch.com/market-research/healthcare/nanotechnology-medical-applications-hlc069a.html. Accessed 3 Jan 2015
Béalle G, Di Corato R, Kolosnjaj-Tabi J et al (2012) Ultra magnetic liposomes for MR imaging, targeting, and hyperthermia. Langmuir 28:11834–11842
Beer AJ, Schwaiger M (2008) Imaging of integrin alphavbeta3 expression. Cancer Metastasis Rev 27:631–644
Blomley MJ, Cooke JC, Unger EC et al (2001) Microbubble contrast agents: a new era in ultrasound. BMJ 322:1222–1225
Brenner TL, Adams VR (1999) First MAb approved for treatment of metastatic breast cancer. J Am Pharm Assoc 39:236–238
Breunig M, Bauer S, Goepferich A (2008) Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur J Pharm Biopharm 68:112–128
Bruchez M Jr, Moronne M, Gin P et al (1998) Semiconductor nanocrystals as fluorescent biological labels. Science 281:2013–2016
Bulte JW, Douglas T, Witwer B et al (2002) Monitoring stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents. Acad Radiol 2:S332–S335
Bunge SD, Boyle TJ, Headley TJ (2003) Synthesis of coinage-metal nanoparticles from mesityl precursors. Nano Lett 3:901–905
Burns AA, Vider J, Ow H et al (2009) Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 9:442–448
Bwatanglang IB, Mohammad F, Yusof NA (2014) Role of multifunctional nanomaterials in disease diagnosis and therapy. J Chem Pharm Res 6:821–844
Cai W, Shin DW, Chen K et al (2006) Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 6:669–676
Cai W, Chen K, Li ZB et al (2007) Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med 48:1862–1870
Cassidy PJ, Radda GK (2005) Molecular imaging perspectives. J R Soc Interface R Soc 2:133–144
Celli JP, Spring BQ, Rizvi I et al (2010) Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 110:2795–2838
Cha EJ, Jang ES, Sun IC et al (2011) Development of MRI/NIRF ‘activatable’ multimodal imaging probe based on iron oxide nanoparticles. J Control Release 155:152–158
Chatterjee DK, Fong LS, Zhang Y (2008) Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 60:1627–1637
Chen F, Nayak TR, Goel S et al (2014a) In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles. Mol Pharm 11:4007–4014
Chen N, Shao C, Qu Y et al (2014b) Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas. ACS Appl Mater Interfaces 6:19850–19857
Cherry SR, Louie AY, Jacobs RE (2008) The integration of positron emission tomography with magnetic resonance imaging. Proc IEEE 96:416–438
Chiang WH, Ho VT, Chen HH et al (2013) Langmuir 29:6434–6443
Chiaviello A, Postiglione I, Palumbo G (2011) Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview. Cancers 3:1014–1041
Choi HS, Frangioni JV (2010) Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol Imaging 9:291–310
Choi HS, Liu W, Misra P et al (2007) Renal clearance of quantum dots. Nat Biotechnol 25:1165–1170
Choi JS, Park JC, Nah H et al (2008) A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. Angew Chem Int Ed Engl 47:6259–6262
Choi HS, Ipe BI, Misra P et al (2009) Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots. Nano Lett 9:2354–2359
Choi KY, Liu G, Lee S et al (2012) Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale 4:330–342
Connor EE, Mwamuka J, Gole A et al (2005) Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325–327
Cormode DP, Skajaa T, Fayad ZA et al (2009) Nanotechnology in medical imaging: probe design and applications. Arterioscler Thromb Vasc Biol 29:992–1000
Cormode DP, Naha PC, Fayad ZA (2014) Nanoparticle contrast agents for computed tomography: a focus on micelles. Contrast Media Mol Imaging 9:37–52
Creighton JA, Blatchford CG, Albrecht MG (1979) Plasma resonance enhancement of Raman scattering by pyridine adsorbed on silver or gold sol particles of size comparable to the excitation wavelength. J Chem Soc Faraday Trans 2: Mol Chem Phys 75:790–798
Crooks RM, Zhao M, Sun L et al (2001) Dendrimer-encapsulated metal nanoparticles: synthesis, characterization, and applications to catalysis. Acc Chem Res 234:181–190
De Leo V, Catucci L, Falqui A et al (2014) Hybrid assemblies of fluorescent nanocrystals and membrane proteins in liposomes. Langmuir 30:1599–1608
de Rosales RTM (2014) Potential clinical applications of bimodal PET-MRI or SPECT-MRI agents. J Labelled Comp Radiopharm 57:298–303
de Rosales RTM, Tavaré R, Glaria A et al (2011a) 99mTc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging. Bioconjugate Chem 22:455–465
de Rosales RTM, Tavaré R, Paul RL et al (2011b) Synthesis of 64CuII–Bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET–MRI Agent. Angew Chem Int Ed Engl 50:5509–5513
Dubertret B, Skourides P, Norris DJ et al (2002) In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298:1759–1762
Egusquiaguirre SP, Igartua M, Hernandez RM et al (2012) Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research. Clin Transl Oncol 14:83–93
Ell PJ (2006) The contribution of PET/CT to improved patient management. Br J Radiol 79:32–36
El-Sayed MA (2001) Some interesting properties of metals confined in time and nanometer space of different shapes. Acc Chem Res 34:257–264
Etheridge ML, Campbell SA, Erdman AG et al (2013) The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine 9:1–14
Fang C, Zhang M (2010) Nanoparticle-based theragnostics: integrating diagnostic and therapeutic potentials in nanomedicine. J Control Release 146:2–5
Fantechi E, Innocenti C, Zanardelli M et al (2014) A smart platform for hyperthermia application in cancer treatment: cobalt-doped ferrite nanoparticles mineralized in human ferritin cages. ACS Nano 8:4705–4719
Figueiredo M, Esenaliev R (2012) PLGA nanoparticles for ultrasound-mediated gene delivery to solid tumors. J Drug Deliv 2012:1–20
Frangioni JV, Kim SW, Ohnishi S et al (2007) Sentinel lymph node mapping with type-II quantum dots methods. Mol Biol 374:147–159
Gao X, Cui Y, Levenson RM et al (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22:969–976
Gelperina S, Kisich K, Iseman MD et al (2005) The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 172:1487–1490
Giljohann DA, Seferos DS, Daniel WL et al (2010) Gold nanoparticles for biology and medicine. Angew Chem Int Ed Engl 49:3280–3294
Gonçalves MS (2009) Fluorescent labeling of biomolecules with organic probes. Chem Rev 109:190–212
Gref R, Minamitake Y, Peracchia MT et al (1994) Biodegradable long-circulating polymeric nanospheres. Science 263:1600–1603
Groneberg DA, Giersig M, Welte T et al (2006) Nanoparticle-based diagnosis and therapy. Curr Drug Targets 7:643–648
Han M, Gao X, Su JZ et al (2001) Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol 19:631–635
Hasebroock KM, Serkova NJ (2009) Toxicity of MRI and CT contrast agents. Expert Opinion Drug Metab Toxicol 5:403–416
Hawkins MJ, Soon-Shiong P, Desai N (2008) Protein nanoparticles as drug carriers in clinical medicine. Adv Drug Deliv Rev 60:876–885
Heidt T, Nahrendorf M (2012) Multimodal iron oxide nanoparticles for hybrid biomedical imaging. NMR Biomed 26:756–765
Herranz M, Ruibal A (2012) Optical imaging in breast cancer diagnosis: the next evolution J. Oncol 2012:8637–8647
Hirsch LR, Gobin AM, Lowery AR et al (2006) Metal nanoshells. Ann Biomed Eng 34:15–22
Ho D, Sun X, Sun S (2011) Monodisperse magnetic nanoparticles for theranostic applications. Acc Chem Res 44:875–882
Horimoto NN, Imura K, Okamoto H (2008) Dye fluorescence enhancement and quenching by gold nanoparticles: direct near-field microscopic observation of shape dependence. Chem Phys Lett 467:105–109
Hu CM, Zhang L, Aryal S et al (2011) Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci 108:10980–10985
Hu F, Li C, Zhang Y et al (2015) Real time in vivo visualization of tumor therapy by a near-infrared-II Ag2S Quantum dot-based theranostic nanoplatform. Nano Res 8:1637–1647
Huang X, El-Sayed IH, Qian W et al (2006) Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 128:2115–2120
Hwang do W, Ko HY, Lee JH et al (2010) A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med 51:98–105
Jang WD, Selim KMK, Lee CH et al (2009) Bioinspired application of dendrimers: from bio-mimicry to biomedical applications. Prog Polym Sci 34:1–23
Janib SM, Moses AS, MacKay JA (2010) Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 62:1052–1063
Jarrett BR, Gustafsson B, Kukis DL et al (2008) Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging. Bioconjug Chem 19:1496–1504
Jennings LE, Long NJ (2009) ‘Two is better than one’—probes for dual-modality molecular imaging. Chem Commun 28:3511–3524
Jeong H, Huh M, Lee SJ et al (2011) Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy. Theranostics 1:230–239
Jia G, Wang H, Yan L et al (2005) Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol 39:1378–1383
Johannsen M, Thiesen B, Wust P et al (2010) Magnetic nanoparticle hyperthermia for prostate cancer. Int J Hyperthermia 26:790–795
Jordan A, Maier-Hauff K, Wust P et al (2006) Nanoparticles for thermotherapy. In: Kumar C (ed) Nanomaterials for cancer therapy. Wiley-VCH, Weinheim, pp 242–258
Josephson L, Kircher MF, Mahmood U et al (2002) Near-infrared fluorescent nanoparticles as combined MR/Optical imaging probes. Bioconj Chem 13:554–560
Kelkar SS, Reineke TM (2011) Theragnostics: combining imaging and therapy. Bioconjug Chem 22:1879–1903
Key J, Leary JF (2014) Nanoparticles for multimodal in vivo imaging in Nanomedicine. Int J Nanomedicine 9:711–726
Khemtong C, Kessinger CW, Gao J (2009) Polymeric nanomedicine for cancer MR imaging and drug delivery. Chem Commun 3497–3510
Kievit FM, Zhang M (2011) Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater 23:H217–H247
Kim S, Lim YT, Soltesz EG et al (2004) Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22:93–97
Kim SW, Zimmer JP, Ohnishi S et al (2005) Engineering InAs(x)P(1-x)/InP/ZnSe III-V alloyed core/shell quantum dots for the near-infrared. J Am Chem Soc 127:10526–10532
Kim D, Kim JW, Jeong YY et al (2009a) Antibiofouling polymer coated gold@ iron oxide nanoparticle as a dual contrast agent for CT and MRI. Bull Korean Chem Soc 30:1855–1857
Kim J, Piao Y, Hyeon T (2009b) Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 38:372–390
Kim K, Kim JH, Park H et al (2010) Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring. J Control Release 146:219–227
Kim D, Yu MK, Lee TS et al (2011) Amphiphilic polymer-coated hybrid nanoparticles as CT/MRI dual contrast agents. Nanotechnology 22:155101
Knapp DW, Adams LG, Degrand AM et al (2007) Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol 52:1700–1708
Kolosnjaj J, Szwarc H, Moussa F (2007) Toxicity studies of carbon nanotubes. Adv Exp Med Biol 620:181–204
Krishanan KM (2010) Biomedical nanomagnetics: a spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans Magn 46:2523–2558
Lammers T, Kiessling F, Hennink WE et al (2010) Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol Pharm 7:1899–1912
Lammers T, Aime S, Hennink WE et al (2011) Theranostic nanomedicine. Acc Chem Res 44:1029–1038
Langer R (1998) Drug delivery and targeting. Nature 392:5–10
Larina IV, Evers BM, Ashitkov TV et al (2005) Enhancement of drug delivery in tumors by using interaction of nanoparticles with ultrasound radiation. Technol Cancer Res Treat 4:217–226
Lee IH, Bulte JW, Schweinhardt P et al (2004) In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp Neurol 187:509–516
Lee SJ, Koo H, Jeong H et al (2011a) Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. J Control Release 152:21–29
Lee SJ, Koo H, Lee DE et al (2011b) Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials 32:4021–4029
Lee DE, Koo H, Sun IC et al (2012) Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev 41:2656–2672
Li X, Qian J, Jiang L et al (2009) Fluorescence quenching of quantum dots by gold nanorods and its application to DNA detection. Appl Phys Lett 94:063111–063113
Li L, Jiang W, Luo K et al (2013) Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking. Theranostics 3:595–615
Liang M, Liu X, Cheng D et al (2010) Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle. Bioconjug Chem 21:1385–1388
Liang S, Zhou Q, Wang M et al (2015) Water-soluble L-cysteine-coated Fe-Pt nanoparticles as dual MRI/CT imaging contrast agent for glioma. Int J Nanomedicine 10:2325–2333
Lin TY, Li YP, Zhang H et al (2013) Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer. Nanomedicine 8:1239–1251
Liu W, Choi HS, Zimmer JP et al (2007) Compact cysteine-coated CdSe(ZnCdS) quantum dots for in vivo applications. J Am Chem Soc 129:14530–14531
Liu J, Yu M, Zhou C et al (2013) Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology. Mater Today 16:477–486
Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3:703–717
Louie A (2010) Multimodality imaging probes: design and challenges. Chem Rev 110:146–3195
Lovrić J, Bazzi HS, Cuie Y et al (2005) Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 83:377–385
Lusic H, Grinstaff MW (2013) X-ray-computed tomography contrast agents. Chem Rev 113:1641–1666
Mader H, Li X, Saleh S et al (2008) Fluorescent silica nanoparticles. Ann N Y Acad Sci 1130:218–223
Maier-Hauff K, Rothe R, Scholz R et al (2007) Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 81:53–60
Makarov VV, Love AJ, Sinitsyna OV et al (2014) “Green” nanotechnologies: synthesis of metal nanoparticles using plants. Acta Naturae 6:35–44
Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545–580
Mazzola L (2003) Commercializing nanotechnology. Nat Biotechnol 21:1137–1143
Medina SH, El-Sayed ME (2009) Dendrimers as carriers for delivery of chemotherapeutic agents. Chem Rev 109:3141–3157
Medintz IL, Uyeda HT, Goldman ER et al (2005) Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 4:435–446
Mitragotri S, Stayton P (2014) Organic nanoparticles for drug delivery and imaging. MRS Bull 39:219–223
Movassaghian S, Merkel OM, Torchilin VP (2015) Applications of polymer micelles for imaging and drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7:691–707
Mura S, Nicolas J, Couvreur P (2013) Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12:991–1003
Murray CB, Kagan CR, Bawendi MG (2000) Synthesis and Characterization of monodispersenanocrystals and close packed nanocrystal assemblies. Annu Rev Mater Sci 30:545–610
Muthu MS, Leong DT, Mei L et al (2014) Nanotheranostics ˗ Application and further development of nanomedicine strategies for advanced theranostics. Theranostics 4:660–677
Nahrendorf M, Zhang H, Hembrador S et al (2008) Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 117:379–387
Nel A, Xia T, Mädler L et al (2006) Toxic potential of materials at the nanolevel. Science 311:622–627
Nel A, Mädler L, Velegol D et al (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543–557
Nie S, Xing Y, Kim GJ et al (2007) Nanotechnology applications in cancer. Annu Rev Biomed Eng 9:257–288
Nikalje AP (2015) Nanotechnology and its Applications in Medicine. Med Chem 5:81–89
Nikoobakht B, El-Sayed MA (2003) Surface-enhanced Raman scattering studies on aggregated gold nanorods. J Phys Chem A 107:3372–3378
Ohnishi S, Lomnes SJ, Laurence RG et al (2005) Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol Imaging 4:172–181
Orendorff CJ, Gearheart L, Jana NR et al (2006) Aspect ratio dependence on surface enhanced Raman scattering using silver and gold nanorod substrates. Phys Chem Chem Phys 8:165–170
Owens DE, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102
Panigrahi S, Kundu S, Ghosh S et al (2004) General method of synthesis for metal nanoparticles. J Nanopart Res 6:411–414
Parhi P, Mohanty C, Sahoo SK (2012) Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discov Today 17:1044–1052
Park JH, von Maltzahn G, Ruoslahti E et al (2008) Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl 47:7284–7288
Park JC, Yu MK, An GI et al (2010a) Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging. Small 6:2863–2868
Park JH, Saravanakumar G, Kim K et al (2010b) Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev 62:28–41
Park SY, Baik HJ, Oh YT et al (2011) A smart polysaccharide/drug conjugate for photodynamic therapy. Angew Chem Int Ed Engl 50:1644–1647
Parungo CP, Ohnishi S, Kim SW et al (2005) Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. J Thorac Cardiovasc Surg 129:844–850
Paull R, Wolfe J, Hébert P et al (2003) Investing in nanotechnology. Nat Biotechnol 21:1144–1147
Pedrosa P, Vinhas R, Fernandes A et al (2015) Gold Nanotheranostics: proof-of-concept or clinical tool? Nanomaterials 5:1853–1879
Pimlott SL, Sutherland A (2011) Molecular tracers for the PET and SPECT imaging of disease. Chem Soc Rev 40:149–162
Pison U, Welte T, Giersig M et al (2006) Nanomedicine for respiratory diseases. Eur J Pharmacol 533:341–350
Rajeeva BB, Menz R, Zheng Y (2014) Towards rational design of multifunctional theranostic nanoparticles: what barriers do we need to overcome? Nanomedicine 9:1767–1770
Ryu JH, Koo H, Sun IC et al (2012) Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy. Adv Drug Deliv Rev 64:1447–1458
Salvador-Morales C, Gao W, Ghatalia P et al (2009) Multifunctional nanoparticles for prostate cancer therapy. Expert Rev Anticancer Ther 9:211–221
Samad A, Sultana Y, Aqil M (2007) Liposomal drug delivery systems: an update review. Curr Drug Deliv 4:297–305
Sanvicens N, Marco MP (2008) Multifunctional nanoparticles—properties and prospects for their use in human medicine. Trends Biotechnol 26:425–433
Sarparanta M, Bimbo LM, Rytkönen J et al (2012) Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution. Mol Pharm 9:654–663
Scherzinger AL, Hendee WR (1986) Basic principles of magnetic resonance imaging- An update. Western J Med 143:782–792
Schultz DA (2003) Plasmon resonant particles for biological detection. Curr Opin Biotechnol 14:13–22
Shapira A, Livney YD, Broxterman HJ et al (2011) Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Drug Resist Updat 14:150–163
Shen M, Shi X (2010) Dendrimer-based organic/inorganic hybrid nanoparticles in biomedical applications. Nanoscale 2:1596–1610
Shi X, Lee I, Baker JR (2008) Acetylation of dendrimer-entrapped gold and silver nanoparticles. J Mater Chem 18:586–593
Singh S (2013) Nanostructures: enhancing potential applications in biomedicals. J Biomater Nanobiotechnol 4:12–16
Slowing II, Vivero-Escoto JL, Wu CW et al (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60:1278–1288
Smith AM, Gao X, Nie S (2004) Quantum dot nanocrystals for in vivo molecular and cellular imaging. Photochem Photobiol 80:377–385
Sosnovik DE, Nahrendorf M, Weissleder R (2007) Molecular magnetic resonance imaging in cardiovascular medicine. Circulation 115:2076–2086
Tada H, Higuchi H, Wanatabe TM et al (2007) In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res 67:1138–1144
Tasis D, Tagmatarchis N, Georgakilas V et al (2003) Soluble carbon nanotubes. Chemistry 9:4000–4008
Taton TA (2002) Nanostructures as tailored biological probes. Trends Biotechnol 20:277–279
Thomas R, Park I-K, Jeong YY (2013) Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer. Int J Mol Sci 14:15910–15930
Torchilin VP (2007) Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 24:1–16
Tsien RY (1998) The green fluorescent protein. Annu Rev Biochem 67:509–544
Tunici P, Bulte JW, Bruzzone MG et al (2006) Brain engraftment and therapeutic potential of stem/progenitor cells derived from mouse skin. J Gene Med 8:506–513
Valden M, Lai X, Goodman DW (1998) Onset of catalytic activity of gold clusters on titania with the appearance of nonmetallic properties. Science 281:1647–1650
van Nostrum CF (2004) Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv Drug Deliv Rev 56:9–16
Walia S, Acharya A (2015) Silica micro/nanospheres for theranostics: from bimodal MRI and fluorescent imaging probes to cancer therapy Beilstein J Nanotechnol 6:546–558
Walia S, Sharma S, Kulurkar PM et al (2016) A bimodal molecular imaging probe based on chitosan encapsulated magneto-fluorescent nanocomposite offers biocompatibility, visualization of specific cancer cells in vitro and lung tissues in vivo. Int J Pharma 498:110–118
Wang L-S, Chuang M-C, Ho JA (2012) Nanotheranostics–a review of recent publications. Int J Nanomedicine 7:4679–4695
Weissleder R (2002) Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2:11–18
Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452:580–589
Willmann JK, van Bruggen N, Dinkelborg LM et al (2008) Molecular imaging in drug development. Nat Rev Drug Discov 7:591–607
Wu H-C, Chang X, Liu L et al (2010) Chemistry of carbon nanotubes in biomedical applications. J Mater Chem 20:1036–1052
Xia B, Zhang W, Shi J et al (2013) Engineered stealth porous silicon nanoparticles via surface encapsulation of bovine serum albumin for prolonging blood circulation in vivo. ACS Appl Mater Interfaces 5:11718–11724
Xiao B, Han MK, Viennois E et al (2015) Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. Nanoscale 7:17745–17755
Xie J, Chen K, Huang J et al (2010a) PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 31:3016–3022
Xie J, Lee S, Chen X (2010b) Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 62:1064–1079
Xing H, Bu W, Zhang S et al (2012) Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 33:1079–1089
Xing Y, Zhao J, Conti PS et al (2014) Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics 4:290–306
Yang X, Hong H, Grailer JJ et al (2011) cRGD-functionalized, DOX-conjugated, and64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 32:4151–4160
Yang S, Sun S, Zhou C et al (2015) Renal clearance and degradation of glutathione-coated copper nanoparticles. Bioconjugate Chem 26:511–519
Yezhelyev MV, Gao X, Xing Y et al (2006) Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol 7:657–667
Yi DK, Sun IC, Ryu JH et al (2010) Matrix metalloproteinase sensitive gold nanorod for simultaneous bioimaging and photothermal therapy of cancer. Bioconjug Chem 21:2173–2177
Zhang Y, Chen W, Zhang J et al (2007) In vitro and in vivo toxicity of CdTe nanoparticles. J Nanosci Nanotechnol 7:497–503
Zhang L, Gu FX, Chan JM et al (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83:761–769
Zhang R, Lu W, Wen X et al (2011) Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis. J Nucl Med 52:958–964
Zhang Y, Xiao L, Popovic K et al (2013) Novel cancer-targeting SPECT/NIRF dual-modality imaging probe 99mTc-PC-1007: synthesis and biological evaluation. Bioorg Med Chem Lett 23:6350–6354
Zheng J, Liu J, Dunne M et al (2007) In vivo performance of a liposomal vascular contrast agent for CT and MR-based image guidance applications. Pharmaceut Res 24:1193–1201
Zhou C, Long M, Qin Y et al (2011) Luminescent gold nanoparticles with efficient renal clearance. Angew Chem Int Ed 50:3168–3172
Zhou J, Yang Y, Zhang CY (2015a) Toward biocompatible semiconductor quantum dots: from biosynthesis and bioconjugation to biomedical application. Chem Rev 115:11669–11717
Zhou Q, Mu K, Jiang L et al (2015b) Glioma-targeting micelles for optical/magnetic resonance dual-mode imaging. Int J Nanomedicine 10:1805–1818
Zhu HW, Xu CL, Wu DH et al (2002) Direct synthesis of long single-walled carbon nanotube strands. Science 296:884–886
Zimmer JP, Kim SW, Ohnishi S (2006) Size series of small indium arsenide-zinc selenide core-shell nanocrystals and their application to in vivo imaging. J Am Chem Soc 128:2526–2527
Acknowledgments
The authors are thankful to the Director, CSIR-IHBT for his constant support and encouragement. The authors are also thankful to Dr. Sudesh Kumar Yadav for his valuable comments and suggestions during the preparation of book chapter. AA acknowledges the financial support from CSIR, GOI in the form of BSC0213 and MLP0068. SW acknowledges CSIR for project fellowship in the form of BSC0213. The CSIR-IHBT Communication Number of this manuscript is 3969.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Walia, S., Acharya, A. (2016). Theragnosis: Nanoparticles as a Tool for Simultaneous Therapy and Diagnosis. In: Yadav, S. (eds) Nanoscale Materials in Targeted Drug Delivery, Theragnosis and Tissue Regeneration. Springer, Singapore. https://doi.org/10.1007/978-981-10-0818-4_6
Download citation
DOI: https://doi.org/10.1007/978-981-10-0818-4_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-0817-7
Online ISBN: 978-981-10-0818-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)